ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,643Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 387

$832K Total Retail Price of All Prescriptions

Rank: 48 out of 387

453 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 453 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

43% of this provider’s 453 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 5,253 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,493 455 S3 1 1
CARISOPRODOL 513 46 R 2 53
SIMVASTATIN 414 231 3 5
LISINOPRIL 316 201 4 3
ZOLPIDEM TARTRATE 308 69 5 16
LEVOTHYROXINE SODIUM 242 166 6 2
METFORMIN HCL 242 160 6 8
NABUMETONE 226 111 8 117
OXYCODONE HCL-ACETAMINOPHEN 210 41 S2 9 98
OMEPRAZOLE 207 122 10 4
CYMBALTA 171 42 11 44
HYDROCHLOROTHIAZIDE 157 99 12 12
OXYCODONE HCL 156 27 S2 13 71
CLONIDINE HCL 150 86 14 38
MELOXICAM 148 88 15 22
RISPERIDONE 140 26 16 70
FUROSEMIDE 137 67 17 7
TRAMADOL HCL 134 73 18 14
CYCLOBENZAPRINE HCL 134 49 R 18 42
NOVOLOG FLEXPEN 132 42 20 249
OXYCONTIN 131 27 S2 21 92
CITALOPRAM HBR 129 65 22 19
PROAIR HFA 116 20 23 47
LEVEMIR FLEXPEN 113 48 24 199
AMLODIPINE BESYLATE 113 79 24 6
POTASSIUM CHLORIDE 110 55 26 9
METOPROLOL TARTRATE 109 63 27 11
ATORVASTATIN CALCIUM 109 82 27 13
LYRICA 108 25 29 66
CIPROFLOXACIN HCL 105 56 30 56
GABAPENTIN 100 49 31 10
SUCRALFATE 97 28 32 128
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 30 32 30
CARVEDILOL 91 57 34 21
ENDOCET 86 15 S2 35 147
PREDNISONE 84 39 36 43
TRIAMTERENE-HCTZ 83 30 37 55
NEXIUM 79 43 38 26
JANUVIA 79 77 38 60
ADVAIR DISKUS 73 35 40 41
ATENOLOL 70 45 41 20
PANTOPRAZOLE SODIUM 68 25 42 48
PEN NEEDLE 68 15 42 173
PRAVASTATIN SODIUM 64 33 44 15
MIRTAZAPINE 62 21 45 64
ESCITALOPRAM OXALATE 61 0 46 73
ALENDRONATE SODIUM 60 60 47 31
GLYBURIDE 57 37 R 48 58
SERTRALINE HCL 55 27 49 23
METOPROLOL SUCCINATE 55 39 49 18
LANTUS SOLOSTAR 52 0 51 102
PAROXETINE HCL 52 22 51 52
CLOPIDOGREL 51 33 53 25
JANUMET 51 25 53 193
FLUTICASONE PROPIONATE 51 25 53 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.